Articoli correlati a SCN2A - Related Disorders

SCN2A - Related Disorders ISBN 13: 9781009530330

SCN2A - Related Disorders - Rilegato

 
9781009530330: SCN2A - Related Disorders

Sinossi

SCN2A encodes a voltage-gated sodium channel (designated NaV1.2) vital for generating neuronal action potentials. Pathogenic SCN2A variants are associated with a diverse array of neurodevelopmental disorders featuring neonatal or infantile onset epilepsy, developmental delay, autism, intellectual disability and movement disorders. SCN2A is a high confidence risk gene for autism spectrum disorder and a commonly discovered cause of neonatal onset epilepsy. This remarkable clinical heterogeneity is mirrored by extensive allelic heterogeneity and complex genotype-phenotype relationships partially explained by divergent functional consequences of pathogenic variants. Emerging therapeutic strategies targeted to specific patterns of NaV1.2 dysfunction offer hope to improving the lives of individuals affected by SCN2A-related disorders. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

EUR 11,70 per la spedizione da Regno Unito a Italia

Destinazione, tempi e costi

Altre edizioni note dello stesso titolo

9781009530378: SCN2A-Related Disorders

Edizione in evidenza

ISBN 10:  1009530372 ISBN 13:  9781009530378
Casa editrice: Cambridge University Press, 2025
Brossura

Risultati della ricerca per SCN2A - Related Disorders

Foto dell'editore

Edited by Alfred L. George, Jr. , Megan Abbott , Kevin J. Bender , Andreas Brunklaus , Scott Demarest , Shawn Egan , Isabel Haviland , Jennifer A. Kearney , Leah Schust Myers , Heather E. Olson , Stephan J. Sanders , Christina SanInocencio , Joseph Symond
ISBN 10: 100953033X ISBN 13: 9781009530330
Nuovo Rilegato
Print on Demand

Da: Revaluation Books, Exeter, Regno Unito

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Hardcover. Condizione: Brand New. 75 pages. 6.00x0.25x9.00 inches. In Stock. This item is printed on demand. Codice articolo __100953033X

Contatta il venditore

Compra nuovo

EUR 72,41
Convertire valuta
Spese di spedizione: EUR 11,70
Da: Regno Unito a: Italia
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello

Foto dell'editore

Abbott, Megan; Bender, Kevin J.; Brunklaus, Andreas; Demarest, Scott; Egan, Shawn; Haviland, Isabel; Kearney, Jennifer A.; Schust Myers, Leah; Olson, Heather E.; Sanders, Stephan J.; SanInocencio, Christina; Symonds, Joseph; Thompson, Christopher H.
ISBN 10: 100953033X ISBN 13: 9781009530330
Nuovo Rilegato

Da: Ria Christie Collections, Uxbridge, Regno Unito

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. In. Codice articolo ria9781009530330_new

Contatta il venditore

Compra nuovo

EUR 73,76
Convertire valuta
Spese di spedizione: EUR 10,51
Da: Regno Unito a: Italia
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Foto dell'editore

Abbott, Megan; Bender, Kevin J.; Brunklaus, Andreas; Demarest, Scott; Egan, Shawn; Haviland, Isabel; Kearney, Jennifer A.; Schust Myers, Leah; Olson, Heather E.; Sanders, Stephan J.; SanInocencio, Christina; Symonds, Joseph; Thompson, Christopher H.
ISBN 10: 100953033X ISBN 13: 9781009530330
Nuovo Rilegato

Da: Biblios, Frankfurt am main, HESSE, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. Codice articolo 18401716295

Contatta il venditore

Compra nuovo

EUR 85,86
Convertire valuta
Spese di spedizione: EUR 7,95
Da: Germania a: Italia
Destinazione, tempi e costi

Quantità: 3 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Jr. Alfred L. George
ISBN 10: 100953033X ISBN 13: 9781009530330
Nuovo Rilegato

Da: AHA-BUCH GmbH, Einbeck, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. Codice articolo 9781009530330

Contatta il venditore

Compra nuovo

EUR 92,94
Convertire valuta
Spese di spedizione: EUR 14,99
Da: Germania a: Italia
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello

Foto dell'editore

Alfred L. George, Jr.
ISBN 10: 100953033X ISBN 13: 9781009530330
Nuovo Rilegato

Da: CitiRetail, Stevenage, Regno Unito

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Hardcover. Condizione: new. Hardcover. SCN2A encodes a voltage-gated sodium channel (designated NaV1.2) vital for generating neuronal action potentials. Pathogenic SCN2A variants are associated with a diverse array of neurodevelopmental disorders featuring neonatal or infantile onset epilepsy, developmental delay, autism, intellectual disability and movement disorders. SCN2A is a high confidence risk gene for autism spectrum disorder and a commonly discovered cause of neonatal onset epilepsy. This remarkable clinical heterogeneity is mirrored by extensive allelic heterogeneity and complex genotype-phenotype relationships partially explained by divergent functional consequences of pathogenic variants. Emerging therapeutic strategies targeted to specific patterns of NaV1.2 dysfunction offer hope to improving the lives of individuals affected by SCN2A-related disorders. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Codice articolo 9781009530330

Contatta il venditore

Compra nuovo

EUR 78,89
Convertire valuta
Spese di spedizione: EUR 35,09
Da: Regno Unito a: Italia
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello

Foto dell'editore

Alfred L. George, Jr.
ISBN 10: 100953033X ISBN 13: 9781009530330
Nuovo Rilegato

Da: AussieBookSeller, Truganina, VIC, Australia

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Hardcover. Condizione: new. Hardcover. SCN2A encodes a voltage-gated sodium channel (designated NaV1.2) vital for generating neuronal action potentials. Pathogenic SCN2A variants are associated with a diverse array of neurodevelopmental disorders featuring neonatal or infantile onset epilepsy, developmental delay, autism, intellectual disability and movement disorders. SCN2A is a high confidence risk gene for autism spectrum disorder and a commonly discovered cause of neonatal onset epilepsy. This remarkable clinical heterogeneity is mirrored by extensive allelic heterogeneity and complex genotype-phenotype relationships partially explained by divergent functional consequences of pathogenic variants. Emerging therapeutic strategies targeted to specific patterns of NaV1.2 dysfunction offer hope to improving the lives of individuals affected by SCN2A-related disorders. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. Codice articolo 9781009530330

Contatta il venditore

Compra nuovo

EUR 94,74
Convertire valuta
Spese di spedizione: EUR 32,22
Da: Australia a: Italia
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello

Foto dell'editore

Alfred L. George, Jr.
ISBN 10: 100953033X ISBN 13: 9781009530330
Nuovo Rilegato

Da: Grand Eagle Retail, Fairfield, OH, U.S.A.

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Hardcover. Condizione: new. Hardcover. SCN2A encodes a voltage-gated sodium channel (designated NaV1.2) vital for generating neuronal action potentials. Pathogenic SCN2A variants are associated with a diverse array of neurodevelopmental disorders featuring neonatal or infantile onset epilepsy, developmental delay, autism, intellectual disability and movement disorders. SCN2A is a high confidence risk gene for autism spectrum disorder and a commonly discovered cause of neonatal onset epilepsy. This remarkable clinical heterogeneity is mirrored by extensive allelic heterogeneity and complex genotype-phenotype relationships partially explained by divergent functional consequences of pathogenic variants. Emerging therapeutic strategies targeted to specific patterns of NaV1.2 dysfunction offer hope to improving the lives of individuals affected by SCN2A-related disorders. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Codice articolo 9781009530330

Contatta il venditore

Compra nuovo

EUR 86,21
Convertire valuta
Spese di spedizione: EUR 65,32
Da: U.S.A. a: Italia
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello